ClinicalTrials.Veeva

Menu

Comparing Pain Relief Between Exparel® Injection vs. On-Q Catheter as the Postsurgical Analgesia Following Total Knee Arthroplasty (TKA)

Rothman Institute Orthopaedics logo

Rothman Institute Orthopaedics

Status

Completed

Conditions

Osteoarthritis: Joint Replacement Surgery

Treatments

Drug: On-Q pain intra-articular catheter
Drug: Exparel

Study type

Interventional

Funder types

Other

Identifiers

NCT02739230
ESmith2016

Details and patient eligibility

About

The goal of this research project is to evaluate the effectiveness of a novel treatment to control pain after Total Knee Arthroplasty (TKA). The proposed approach to manage pain and eliminate risks associated with catheters is the use of Exparel injection into the joint at the time of surgery.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. Adults scheduled to undergo primary total knee replacement
  2. Willing and able to provide informed consent

Trial design

0 participants in 2 patient groups

Exparel Injection
Active Comparator group
Treatment:
Drug: Exparel
On-Q intraarthicual catheter placement
Active Comparator group
Treatment:
Drug: On-Q pain intra-articular catheter

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems